Change in Biotie Therapies' Financial Calendar 2015
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. Stock Exchange
Release 26 May 2015 at 4.45 p.m.
Change in Biotie Therapies' Financial Calendar 2015
Biotie Therapies Corp. ("Biotie") will now publish its Interim Financial Report
for:
* January to June 2015 on 20 August 2015; the previously announced date was
30 July
* January to September 2015 on 12 November 2015; the previously announced date
was 29 October
Turku, 26 May 2015
Biotie Therapies Corp.
Timo Veromaa
President and CEO
For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi(at)biotie.com
www.biotie.com
DISTRIBUTION:
NASDAQ OMX Helsinki Ltd
Main Media
About Biotie
Biotie is a specialized drug development company focused on products for
neurodegenerative and psychiatric disorders. Biotie's development has delivered
Selincro (nalmefene) for alcohol dependence, which received European marketing
authorization in 2013 and is currently being rolled out across Europe by partner
Lundbeck. The current development products include tozadenant for Parkinson's
disease, which is transitioning into Phase 3 development, and two additional
compounds which are in Phase 2 development for cognitive disorders including
Parkinson's disease dementia, and primary sclerosing cholangitis (PSC), a rare
fibrotic disease of the liver.
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotie Therapies Oyj via GlobeNewswire
[HUG#1923920]
Unternehmensinformation / Kurzprofil:
Datum: 26.05.2015 - 15:46 Uhr
Sprache: Deutsch
News-ID 395749
Anzahl Zeichen: 2226
contact information:
Town:
Turku
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 173 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Change in Biotie Therapies' Financial Calendar 2015"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
